Hormonal Smartphone Diagnostics
Mobile point-of-care diagnostics are paramount for the provision of healthcare. Hormonal diagnostics are powerful tools to monitor timely changes in human physiology. Hormone concentrations in serum directly correlate with urine excretions with minor time delays. Therefore, rapid tests for hormones in urine have been widely used for decades as means of early diagnostics, particularly in lateral flow immunoassay formats. However, the challenge of reading and interpreting these binary tests remains. Here we present a method for utilizing mobile technologies to quantitatively read and interpret hormonal test strips. The method demonstrates the detection of a urinary by-product of progesterone, pregnanediol glucuronide (PdG), and its relation to ovulation and the fertility cycle.
Key wordsSmartphone Diagnostics Mobile Medical Application Quantitative assays Hormones Progesterone PdG Ovulation
The authors acknowledge MFB Fertility Inc. for providing the PdG lateral flow test strips.
- 15.Blackwell LF, Brown JB, Cooke D (1998) Definition of the potentially fertile period from urinary steroid excretion rates. Part II. A threshold value for pregnanediol glucuronide as a marker for the end of the potentially fertile period in the human menstrual cycle. Steroids 63:5–13CrossRefPubMedGoogle Scholar
- 27.Blackwell LF, Vigil P, Alliende ME, Brown S, Festin M, Cooke DG (2016) Monitoring of ovarian activity by measurement of urinary excretion rates using the ovarian monitor, part IV: the relationship of the pregnanediol glucuronide threshold to basal body temperature and cervical mucus as markers for the beginning of the post-ovulatory infertile period. Hum Reprod 31:445–453PubMedGoogle Scholar
- 30.Blackwell LF, Vigil P, Cooke DG, d'Arcangues C, Brown JB (2013) Monitoring of ovarian activity by daily measurement of urinary excretion rates of oestrone glucuronide and pregnanediol glucuronide using the ovarian monitor, part III: variability of normal menstrual cycle profiles. Hum Reprod 28:3306–3315CrossRefPubMedGoogle Scholar
- 32.Blackwell LF, Vigil P, Gross B, d'Arcangues C, Cooke DG, Brown JB (2012) Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the ovarian monitor, part II: reliability of home testing. Hum Reprod 27:550–557CrossRefPubMedGoogle Scholar
- 33.Blackwell LF, Brown JB, Vigil P, Gross B, Sufi S, d'Arcangues C (2003) Hormonal monitoring of ovarian activity using the ovarian monitor, part I. Validation of home and laboratory results obtained during ovulatory cycles by comparison with radioimmunoassay. Steroids 68:465–476CrossRefPubMedGoogle Scholar